Your browser doesn't support javascript.
loading
Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma.
Dettling, Steffen; Stamova, Slava; Warta, Rolf; Schnölzer, Martina; Rapp, Carmen; Rathinasamy, Anchana; Reuss, David; Pocha, Kolja; Roesch, Saskia; Jungk, Christine; Warnken, Uwe; Eckstein, Volker; Grabe, Niels; Schramm, Christoph; Weigand, Markus A; von Deimling, Andreas; Unterberg, Andreas; Beckhove, Philipp; Herold-Mende, Christel.
Afiliación
  • Dettling S; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital of Heidelberg, Heidelberg, Germany.
  • Stamova S; Regensburg Center for Interventional Immunology (RCI) and University Medical Center of Regensburg, Regensburg, Germany.
  • Warta R; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital of Heidelberg, Heidelberg, Germany.
  • Schnölzer M; Functional Proteome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Rapp C; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital of Heidelberg, Heidelberg, Germany.
  • Rathinasamy A; Regensburg Center for Interventional Immunology (RCI) and University Medical Center of Regensburg, Regensburg, Germany.
  • Reuss D; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Pocha K; German Cancer Consortium (DKTK), CCU Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Roesch S; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital of Heidelberg, Heidelberg, Germany.
  • Jungk C; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital of Heidelberg, Heidelberg, Germany.
  • Warnken U; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital of Heidelberg, Heidelberg, Germany.
  • Eckstein V; Functional Proteome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Grabe N; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Schramm C; Hamamatsu Tissue Imaging and Analysis Center (TIGA), BIOQUANT, University of Heidelberg, Heidelberg, Germany.
  • Weigand MA; Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.
  • von Deimling A; Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Unterberg A; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Beckhove P; German Cancer Consortium (DKTK), CCU Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Herold-Mende C; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital of Heidelberg, Heidelberg, Germany.
Clin Cancer Res ; 24(12): 2951-2962, 2018 06 15.
Article en En | MEDLINE | ID: mdl-29563135
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Biomarcadores de Tumor / Glioma / Isocitrato Deshidrogenasa / Mutación Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Biomarcadores de Tumor / Glioma / Isocitrato Deshidrogenasa / Mutación Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Alemania